Schleutker J - Search Results

1

Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients.

Nurmi A, Muranen TA, Pelttari LM, Kiiski JI, Heikkinen T, Lehto S, Kallioniemi A, Schleutker J, Bützow R, Blomqvist C, Aittomäki K, Nevanlinna H. Nurmi A, et al. Among authors: schleutker j. Int J Cancer. 2019 Nov 15;145(10):2692-2700. doi: 10.1002/ijc.32309. Epub 2019 Apr 25. Int J Cancer. 2019. PMID: 30927251 Free PMC article.

2

Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.

Matikainen MP, Schleutker J, Mörsky P, Kallioniemi OP, Tammela TL. Matikainen MP, et al. Among authors: schleutker j. Clin Cancer Res. 1999 Jun;5(6):1275-9. Clin Cancer Res. 1999. PMID: 10389909

3

Nationwide cancer family ascertainment using Finnish Cancer Registry data on family names and places of birth for 35,761 prostate cancer patients.

Matikainen MP, Sankila R, Schleutker J, Kallioniemi OP, Pukkala E. Matikainen MP, et al. Among authors: schleutker j. Int J Cancer. 2000 Oct 15;88(2):307-12. doi: 10.1002/1097-0215(20001015)88:2<307::aid-ijc25>3.0.co;2-7. Int J Cancer. 2000. PMID: 11004685 Free article.

4

Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.

Mononen N, Syrjäkoski K, Matikainen M, Tammela TL, Schleutker J, Kallioniemi OP, Trapman J, Koivisto PA. Mononen N, et al. Among authors: schleutker j. Cancer Res. 2000 Nov 15;60(22):6479-81. Cancer Res. 2000. PMID: 11103816

5

Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers: a population-based, cancer registry study in Finland.

Matikaine MP, Pukkala E, Schleutker J, Tammela TL, Koivisto P, Sankila R, Kallioniemi OP. Matikaine MP, et al. Among authors: schleutker j. Cancer Causes Control. 2001 Apr;12(3):223-30. doi: 10.1023/a:1011283123610. Cancer Causes Control. 2001. PMID: 11405327

6

ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.

Rökman A, Ikonen T, Mononen N, Autio V, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J. Rökman A, et al. Among authors: schleutker j. Cancer Res. 2001 Aug 15;61(16):6038-41. Cancer Res. 2001. PMID: 11507049

7

New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.

Marchesani M, Hakkarainen A, Tuomainen TP, Kaikkonen J, Pukkala E, Uimari P, Seppälä E, Matikainen M, Kallioniemi OP, Schleutker J, Lehtimäki T, Salonen JT. Marchesani M, et al. Among authors: schleutker j. J Natl Cancer Inst. 2003 Jun 4;95(11):812-8. doi: 10.1093/jnci/95.11.812. J Natl Cancer Inst. 2003. PMID: 12783936

8

CHEK2 variants associate with hereditary prostate cancer.

Seppälä EH, Ikonen T, Mononen N, Autio V, Rökman A, Matikainen MP, Tammela TL, Schleutker J. Seppälä EH, et al. Among authors: schleutker j. Br J Cancer. 2003 Nov 17;89(10):1966-70. doi: 10.1038/sj.bjc.6601425. Br J Cancer. 2003. PMID: 14612911 Free PMC article.

9

Germ-line alterations in MSR1 gene and prostate cancer risk.

Seppälä EH, Ikonen T, Autio V, Rökman A, Mononen N, Matikainen MP, Tammela TL, Schleutker J. Seppälä EH, et al. Among authors: schleutker j. Clin Cancer Res. 2003 Nov 1;9(14):5252-6. Clin Cancer Res. 2003. PMID: 14614006

10

Kruppel-like factor 6 germ-line mutations are infrequent in Finnish hereditary prostate cancer.

Koivisto PA, Hyytinen ER, Matikainen M, Tammela TL, Ikonen T, Schleutker J. Koivisto PA, et al. Among authors: schleutker j. J Urol. 2004 Aug;172(2):506-7. doi: 10.1097/01.ju.0000129242.88182.e1. J Urol. 2004. PMID: 15247715

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page